Proton MR spectroscopy of squamous cell carcinoma of the extracranial head and neck: in vitro and in vivo studies
- PMID: 9194433
- PMCID: PMC8337295
Proton MR spectroscopy of squamous cell carcinoma of the extracranial head and neck: in vitro and in vivo studies
Abstract
Purpose: To determine the ability of in vitro one-dimensional and two-dimensional proton MR spectroscopy to help differentiate squamous cell carcinoma of the extracranial head and neck from normal tissues and to correlate the in vitro observations with clinical studies.
Methods: In vitro 1-D and 2-D correlated proton MR spectroscopy (11 T) was performed in tissue specimens of squamous cell carcinoma of the head and neck (n = 19), in normal tissue (n = 13), in metastatic cervical lymph nodes (n = 3), and in a squamous cell carcinoma cell line. In vivo 1-D proton MR spectroscopy (1.5 T) was performed in patients with squamous cell carcinoma (n = 7) and in healthy volunteers (n = 7). The ratio of the areas under the choline (Cho) and creatine (Cr) resonances were calculated for 1-D proton MR spectra for the in vitro tissue studies and correlated with the in vivo studies. Data from in vitro 2-D correlated spectroscopy were analyzed for differences in the presence or absence of various metabolites in samples of tumor and normal tissue. Statistical analysis consisted of 2 x 2 factorial repeated measures analysis of variance (ANOVA), discriminate analysis, and chi2 test.
Results: The mean in vitro 1-D proton MR spectroscopic Cho/Cr ratio was significantly higher in tumor than in normal tissue. The difference between the mean ratios appeared to increase with increasing echo time. All in vivo tumor Cho/Cr ratios were greater than the calculated mean in vitro tumor ratio, whereas six of the seven volunteers had no detectable Cho and Cr resonances. Two-dimensional correlated MR spectroscopic data revealed that a variety of amino acids have a significantly greater likelihood of being detected in tumor than in normal tissues.
Conclusions: One-dimensional and 2-D proton MR spectroscopy can help differentiate primary squamous cell carcinoma and nodal metastases containing squamous cell carcinoma from normal tissue both in vitro and in vivo. In addition, 2-D spectroscopy can help identify the presence of certain amino acids in squamous cell carcinoma that are not detected in normal tissue.
Similar articles
-
In vivo proton MR spectroscopy of primary and nodal nasopharyngeal carcinoma.AJNR Am J Neuroradiol. 2004 Mar;25(3):484-90. AJNR Am J Neuroradiol. 2004. PMID: 15037477 Free PMC article.
-
In vivo 1H MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen tension measurements.AJNR Am J Neuroradiol. 2000 Jan;21(1):183-93. AJNR Am J Neuroradiol. 2000. PMID: 10669248 Free PMC article. Clinical Trial.
-
The choline/creatine ratio in five benign neoplasms: comparison with squamous cell carcinoma by use of in vitro MR spectroscopy.AJNR Am J Neuroradiol. 2000 Nov-Dec;21(10):1930-5. AJNR Am J Neuroradiol. 2000. PMID: 11110549 Free PMC article.
-
In vitro 1H MR spectroscopy of squamous cell carcinoma of the extracranial head and neck.Neuroimaging Clin N Am. 1998 Nov;8(4):835-47. Neuroimaging Clin N Am. 1998. PMID: 9769345 Review.
-
Magnetic resonance spectroscopy of head and neck neoplasms.Top Magn Reson Imaging. 2004 Apr;15(2):87-94. doi: 10.1097/01.rmr.0000130599.19502.ba. Top Magn Reson Imaging. 2004. PMID: 15269611 Review.
Cited by
-
Translating preclinical MRI methods to clinical oncology.J Magn Reson Imaging. 2019 Nov;50(5):1377-1392. doi: 10.1002/jmri.26731. Epub 2019 Mar 29. J Magn Reson Imaging. 2019. PMID: 30925001 Free PMC article. Review.
-
Therapeutic response in musculoskeletal soft tissue sarcomas: evaluation by MRI.NMR Biomed. 2011 Jul;24(6):750-63. doi: 10.1002/nbm.1731. NMR Biomed. 2011. PMID: 21793077 Free PMC article. Review.
-
Metabolomics study of oral cancers.Metabolomics. 2019 Feb 8;15(2):22. doi: 10.1007/s11306-019-1483-8. Metabolomics. 2019. PMID: 30830419 Review.
-
Diffusion-weighted imaging in head and neck cancers.Future Oncol. 2009 Sep;5(7):959-75. doi: 10.2217/fon.09.77. Future Oncol. 2009. PMID: 19792966 Free PMC article. Review.
-
Prediction of treatment response in head and neck cancer by magnetic resonance spectroscopy.AJNR Am J Neuroradiol. 2005 Sep;26(8):2108-13. AJNR Am J Neuroradiol. 2005. PMID: 16155166 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical